Form 4: Relay Therapeutics' Chief Legal Officer Sells Shares to Cover Tax Obligations
SEC Form 4
Brian Adams, Chief Legal Officer of Relay Therapeutics, sold 299 shares of common stock on December 27, 2024, to cover income tax withholding obligations upon the vesting of restricted stock units.
Summary
- Brian Adams, the Chief Legal Officer of Relay Therapeutics, Inc. (RLAY), sold 299 shares of common stock on December 27, 2024.
- The sale was executed at a price of $4.38 per share.
- This transaction was to cover income tax withholding obligations related to the vesting of 992 restricted stock units (RSUs) on December 26, 2024.
- Following the transaction, Adams directly owns 321,608 shares of Relay Therapeutics, Inc., which includes 277,333 shares underlying RSUs.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations, and it doesn't necessarily indicate a positive or negative sentiment towards the company's future prospects.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This particular filing indicates a sale of shares to cover tax obligations, which is a common practice.
Key Dates
| Date | Description |
|---|---|
| 12/26/2024 | Vesting of 992 restricted stock units (RSUs). |
| 12/27/2024 | Sale of 299 shares of common stock by Brian Adams. |
| 12/31/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.